In the startup world, the power dynamics have dramatically shifted. Recent reports show that in 2025, 41 percent of all venture capital dollars deployed in the US went to just 10 companies. For life sciences firms, medical device companies, and other research organizations requiring laboratory space, achieving operational readiness across the enterprise is essential to maintaining competitiveness for investment capital and preserving existing cash flow.